Synergistic Activities of Moxifloxacin Combined with Piperacillin-Tazobactam or Cefepime against Klebsiella pneumoniae, Enterobacter cloacae, and Acinetobacter baumannii Clinical Isolates

類似資料

• In vitro pharmacodynamics of piperacillin, piperacillin-tazobactam, and ciprofloxacin alone and in combination against Staphylococcus aureus, Klebsiella pneumoniae, Enterobacter cloacae, and Pseudomonas aeruginosa.
  著者:: Hyatt, J M, 等
  出版事項: (1995)
• 2436. Use of Piperacillin/Tazobactam vs. Cefepime or Carbapenem for Infections Due to Serratia, Citrobacter, or Enterobacter
  著者:: Go, James, 等
  出版事項: (2018)
• Emergence of Resistance in Klebsiella aerogenes to Piperacillin-Tazobactam and Ceftriaxone
  著者:: Custodio, Marco M., 等
  出版事項: (2021)
• Enterobacter endophthalmitis: Treatment with intravitreal tazobactam- piperacillin
  著者:: Singh, Trehan Hemant, 等
  出版事項: (2007)
• Comparative In Vitro Activities of Ciprofloxacin, Clinafloxacin, Gatifloxacin, Levofloxacin, Moxifloxacin, and Trovafloxacin against Klebsiella pneumoniae, Klebsiella oxytoca, Enterobacter cloacae, and Enterobacter aerogenes Clinical Isolates with Alterations in GyrA and ParC Proteins
  著者:: Brisse, Sylvain, 等
  出版事項: (1999)